Navigation Links
Stem Cell Innovations, Inc., Files New Patent Application Regarding Pluripotent Stem Cell Production
Date:1/23/2009

HOUSTON, Jan. 23 /PRNewswire-FirstCall/ -- Stem Cell Innovations, Inc., (Pink Sheets: SCLL) announced today that it has filed a new patent application for the production of pluripotent stem cells from primordial germ cells. "We have been working for several years to develop a more effective method for producing stem cells from germ cells," said CEO James H. Kelly, PhD. "This filing was submitted to secure our intellectual property prior to publication in the scientific literature."

The Company has been developing PluriCells(TM) for use in drug discovery. "The method in this application provides for a substantial improvement in both the yield and quality of stem cells produced. It builds on our already strong IP position in germ cell-derived stem cells and will allow us to expand in new directions," explained Kelly.

About Stem Cell Innovations, Inc.

SCLL is a cell biology company based in Houston, TX. The Company's ACTIVTox system is a human liver based model for high throughput toxicity testing. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells, have the potential to aid in drug discovery, toxicology, and cell therapy.

Additional information is available at www.stemcellinnovations.com and at www.activtox.com.

ACTIVTox and PluriCells are Trademarks of Stem Cell Innovations, Inc.

Forward Looking Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward looking statements. Forward-Looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We use words such as "expects", "intends", "believes", "may", "will" and "anticipates" to indicate forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including, but not limited to, those risks and uncertainties detailed in the Company's periodic reports filed with the Securities and Exchange Commission. We caution that these risk factors may not be exhaustive. We operate in a continually changing business environment, and new risk factors emerge from time to time. We cannot predict these new risk factors, nor can we assess the effect, if any, of the new risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ from those expressed or implied by these forward-looking statements.

If any one or more of these expectations and assumptions proves incorrect, actual results will likely differ materially from those contemplated by the forward-looking statements. Even if all of the foregoing assumptions and expectations prove correct, actual results may still differ materially from those expressed in the forward-looking statements as a result of factors we may not anticipate or that may be beyond our control. While we cannot assess the future impact that any of these differences could have on our business, financial condition, results of operations and cash flows or the market price of shares of our common stock, the difference could be significant. We do not undertake to update any forward-looking statements made by us, whether as a result of new information, future events or otherwise. You are cautioned.


'/>"/>
SOURCE Stem Cell Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
2. Young Innovations, Inc. Provides Third Quarter Conference Call Details
3. Enhanced Care Initiatives (HC Innovations, Inc.) Contracts with HIP and GHI to Create a Medical Home Network Project with Support from the Commonwealth Fund
4. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
5. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend, Authorizes Share Repurchase Program and Announces Election of New Officers
6. Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008
7. Young Innovations, Inc. Provides First Quarter Conference Call Details
8. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
9. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
10. Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
11. Young Innovations, Inc. Provides Fourth Quarter Conference Call Details
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Today, Our ... Washington, MO with a public ribbon cutting ceremony. Since opening over a ... an alternative to the emergency room. The new Our Urgent Care walk-in clinic ...
(Date:5/22/2017)... ... May 22, 2017 , ... WeightZone ... Wellocity to empower WeightZone Factor members to track their exercise patterns, monitor behavioral ... health education, all on their mobile phones. It also provides social networks for ...
(Date:5/21/2017)... ... May 20, 2017 , ... Pixel Film Studios presents a ... in Final Cut Pro X. The business-oriented elements and dignified animations are designed ... Corporate will deliver a professional and distinguished look to any multi-line text animation ...
(Date:5/21/2017)... , ... May 21, 2017 , ... Following the tragic ... York became the first state to require that hospitals follow a protocol to quickly ... the medical community as to whether such steps would have saved Rory or anyone ...
(Date:5/19/2017)... ... May 19, 2017 , ... When Kyle Busch graduates from ... will already appear on two major research studies that could impact the health of ... Matt Daggett, KCU alumnus and an orthopedic surgeon, alongside an international team trying to ...
Breaking Medicine News(10 mins):
(Date:5/2/2017)... 2, 2017  George Clinical, a leading full-service CRO ... and Vector Oncology, a Memphis ... announced today that George Clinical has acquired Vector ... the dual purpose of strengthening the ability of ... delivery solutions throughout the Asia-Pacific ...
(Date:5/2/2017)... , May 2, 2017  Bayer and Project Apis ... from Healthy Hives 2020, a $1 million research effort to ... by the end of 2020. The grant ... Rueppell , University of North Carolina at Greensboro, who will ... bees; Dr. Edmund Stark , Michigan ...
(Date:4/28/2017)... Holdings, Inc. ("Hill-Rom") (NYSE: HRC ) ... quarter ended March 31, 2017, and raised its ... updated guidance reflect the contribution from the Mortara ... February 14, 2017.  For the fiscal ... diluted share compared to $0.33 per diluted share ...
Breaking Medicine Technology: